Addition

A venture capital firm that invests in founder-led, technology-enabled companies.

Venture Capital Active New York City, United States Est. 1995
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages

About

Addition is a venture capital firm that invests in founder-led, technology-enabled companies. It is primarily based out of New York City, United States. As of April 2026, Addition is an active investor, having invested in 76 companies, with 8 new investments in the last 12 months. It primarily invests in Series B rounds in United States-based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and FinTech.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2
Industrial Technologies1
Fintech & Insurtech1
Cyber Security1

Q&A

What is Addition's most notable exit?
Addition's most notable exit is Navan, which had a POEvent in October 2025 with a valuation of $6.2 billion. Navan raised $923 million in capital and is listed on NASDAQ.
Which sectors does Addition focus on for its investments?
Addition shows a concentration in Health Tech & Life Sciences, with two portfolio companies. They also have investments in Industrial Technologies, Fintech & Insurtech, and Cyber Security.
Can you name some of Addition's key portfolio companies?
Addition's key portfolio companies include Nym, a Natural Language Understanding platform for healthcare, and Snyk, a developer security platform.
What was Addition's most recent investment activity?
Addition participated in an investment round in October 2024, according to startupim data.
What is the funding stage distribution of Addition's investments?
Addition has invested across various stages, including Seed, B Round, C Round (with one follow-on), D Round, and E Round.
Has Addition made any recent investments in the Health Tech & Life Sciences sector?
Yes, Addition invested in Nym, a Natural Language Understanding company for healthcare, which raised a Series C round of $94.5 million.
What is the total capital raised by Addition's portfolio company proteanTecs?
proteanTecs, a portfolio company of Addition, has raised $241 million through its Series D funding stage.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded1995

Radar intelligence

Patents

EPO216

Publications (Crossref)

Works10